Cagrilintide as a stand-alone drug has been studied through Phase 2, [1] but most of the headline cagrilintide numbers people cite actually come from CagriSema the fixed-dose combination of cagrilintide 2.4 mg with semaglutide 2.4 mg which advanced into the Phase 3 REDEFINE program
AHK-Cu research has focused on supporting the hair growth cycle, which may be of interest to those experiencing thinning
Ellouk-Achard S, Levresse V, Martin C, Pham-Huy C, Dutertre-Catella H, Thevenin M et al
Copper Peptide (GHK-Cu) is a biomimetic tripeptide complexed with copper ions, recognized for its role in cosmetic formulations targeting skin revitalization and improved appearance
Vogel DG, Malekzadeh MH, Cornford ME, Schneider JA, Shields WD, Vinters HV (1990) Central nervous system involvement in nephropathic cystinosis